Trial Profile
A trial comparing telbivudine with lamivudine in liver failure patients with chronic HBV infection
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Nov 2015
Price :
$35
*
At a glance
- Drugs Telbivudine (Primary) ; Lamivudine
- Indications Hepatitis B; Liver failure
- Focus Therapeutic Use
- 29 Nov 2015 New trial record